Literature DB >> 20585514

Emerging roles of collapsin response mediator proteins (CRMPs) as regulators of voltage-gated calcium channels and synaptic transmission.

Yuying Wang, Joel M Brittain, Sarah M Wilson, Rajesh Khanna.   

Abstract

Presynaptic N-type voltage-gated Ca(2+) channels (Cav2.2) form part of an extensive macromolecular complex in the presynaptic terminal. Regulation of Cav2.2 is achieved via protein-protein interactions within the terminal and can directly impact transmitter release which is dependent on Ca(2+) influx via these Cav2.2. We recently identified a novel Cav2.2 interacting partner-the collapsin response mediator protein (CRMP).1 CRMPs are a family of five proteins implicated in signal transduction of neurite outgrowth and axonal guidance. We showed that CRMP-2, a wellstudied member of this family, interacted with Cav2.2 via direct binding to cytoplasmic loops of Cav2.2. Depolarization enhanced the interaction. Further studies revealed that CRMP-2 facilitated an increase in Cav2.2 current density by inserting more Cav2.2 at the cell surface. As a consequence of CRMP-2-mediated increase in Ca(2+) influx, release of the excitatory neurotransmitter glutamate was also increased. CRMP-2 localized to synapses where, surprisingly, its overexpression increased synapse size. We hypothesize that the CRMP-2-calcium channel interaction represents a novel mechanism for modulation of Ca(2+) influx into nerve terminals and, hence, of synaptic strength. In this addendum, we further discuss the significance of this study and the possible implications to the field.

Entities:  

Keywords:  CRMP-2; Cav2.2; axonal outgrowth; growth cone; presynaptic calcium channels; surface trafficking; synaptic transmission

Year:  2010        PMID: 20585514      PMCID: PMC2889978          DOI: 10.4161/cib.3.2.10620

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  30 in total

1.  TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone.

Authors:  Christopher C Quinn; Esteban Chen; Tashi G Kinjo; Gail Kelly; Alexander W Bell; Robert C Elliott; Peter S McPherson; Susan Hockfield
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 2.  Activity-dependent neuronal differentiation prior to synapse formation: the functions of calcium transients.

Authors:  Nicholas C Spitzer
Journal:  J Physiol Paris       Date:  2002 Jan-Mar

3.  Association of neuronal calcium channels with modular adaptor proteins.

Authors:  A Maximov; T C Südhof; I Bezprozvanny
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

4.  Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity.

Authors:  Young Chan Chae; Sukmook Lee; Kyun Heo; Sang Hoon Ha; Yonwoo Jung; Jong Hyun Kim; Yasuo Ihara; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Cell Signal       Date:  2009-08-08       Impact factor: 4.315

5.  Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.

Authors:  Yutaka Uchida; Toshio Ohshima; Yukio Sasaki; Hiromi Suzuki; Shigeki Yanai; Naoya Yamashita; Fumio Nakamura; Kohtaro Takei; Yasuo Ihara; Katsuhiko Mikoshiba; Papachan Kolattukudy; Jerome Honnorat; Yoshio Goshima
Journal:  Genes Cells       Date:  2005-02       Impact factor: 1.891

6.  Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.

Authors:  Xian Xuan Chi; Brian S Schmutzler; Joel M Brittain; Yuying Wang; Cynthia M Hingtgen; Grant D Nicol; Rajesh Khanna
Journal:  J Cell Sci       Date:  2009-11-10       Impact factor: 5.285

7.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.

Authors:  Yuko Fukata; Tomohiko J Itoh; Toshihide Kimura; Céline Ménager; Takashi Nishimura; Takashi Shiromizu; Hiroyasu Watanabe; Naoyuki Inagaki; Akihiro Iwamatsu; Hirokazu Hotani; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

Review 8.  Physical link and functional coupling of presynaptic calcium channels and the synaptic vesicle docking/fusion machinery.

Authors:  Z H Sheng; R E Westenbroek; W A Catterall
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

Review 9.  The CRMP family of proteins and their role in Sema3A signaling.

Authors:  Eric F Schmidt; Stephen M Strittmatter
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK.

Authors:  Benjamin Adam Samuels; Yi-Ping Hsueh; Tianzhi Shu; Haoya Liang; Huang-Chun Tseng; Chen-Jei Hong; Susan C Su; Janet Volker; Rachael L Neve; David T Yue; Li-Huei Tsai
Journal:  Neuron       Date:  2007-12-06       Impact factor: 17.173

View more
  25 in total

1.  A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.

Authors:  Matthew S Ripsch; Carrie J Ballard; May Khanna; Joyce H Hurley; Fletcher A White; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2012-03       Impact factor: 1.757

2.  In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.

Authors:  Yuying Wang; Joel M Brittain; Brian W Jarecki; Ki Duk Park; Sarah M Wilson; Bo Wang; Rachel Hale; Samy O Meroueh; Theodore R Cummins; Rajesh Khanna
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 3.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

4.  VOLTAGE-GATED CALCIUM CHANNELS ARE NOT AFFECTED BY THE NOVEL ANTI-EPILEPTIC DRUG LACOSAMIDE.

Authors:  Yuying Wang; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2011-03       Impact factor: 1.757

5.  Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2).

Authors:  Joel M Brittain; Liang Chen; Sarah M Wilson; Tatiana Brustovetsky; Xiang Gao; Nicole M Ashpole; Andrei I Molosh; Haitao You; Andy Hudmon; Anantha Shekhar; Fletcher A White; Gerald W Zamponi; Nickolay Brustovetsky; Jinhui Chen; Rajesh Khanna
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

6.  Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.

Authors:  Joel M Brittain; Rui Pan; Haitao You; Tatiana Brustovetsky; Nickolay Brustovetsky; Gerald W Zamponi; Wei-Hua Lee; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2012-01-01       Impact factor: 2.581

7.  Postnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain.

Authors:  Atsuhiro Tsutiya; Ritsuko Ohtani-Kaneko
Journal:  J Anat       Date:  2012-07-22       Impact factor: 2.610

8.  Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.

Authors:  Sarah M Wilson; Joel M Brittain; Andrew D Piekarz; Carrie J Ballard; Matthew S Ripsch; Theodore R Cummins; Joyce H Hurley; May Khanna; Nathan M Hammes; Brian C Samuels; Fletcher A White; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

9.  Use of lacosamide in children with refractory epilepsy.

Authors:  Marcia L Buck; Howard P Goodkin
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

10.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.